James Posada
Vorstandsvorsitzender bei Resolve Therapeutics LLC
Profil
James Posada is the founder of Resolve Therapeutics LLC, which was founded in 2011.
He held the title of Chief Executive Officer & Director.
Dr. Posada's former jobs include Senior Director-Business Development at Protein Design Labs, Inc., Manager at Eli Lilly & Co., Principal at Merck & Co., Inc., Head-Business Development at Trellis Bioscience, Inc., Principal at the University of Vermont, and SVP-Business & Market Development at GlycoFi, Inc. Dr. Posada's education history includes an undergraduate degree from Eastern Connecticut State University and an MBA and doctorate from the University of Vermont.
Aktive Positionen von James Posada
Unternehmen | Position | Beginn |
---|---|---|
Resolve Therapeutics LLC
Resolve Therapeutics LLC BiotechnologyHealth Technology Resolve Therapeutics LLC operates as a biotechnology company. It engages in the development of biotechnology drugs. The firm specializes in treatment of debilitating autoimmune diseases such as Systemic Lupus Erythematous and Sjogren’s syndrome. The company was founded by James Posada in 2010 and is headquartered in Seattle, WA. | Vorstandsvorsitzender | 01.01.2011 |
Ehemalige bekannte Positionen von James Posada
Unternehmen | Position | Ende |
---|---|---|
ELI LILLY AND COMPANY | Corporate Officer/Principal | 01.01.2002 |
MERCK & CO., INC. | Corporate Officer/Principal | - |
Trellis Bioscience, Inc.
Trellis Bioscience, Inc. BiotechnologyHealth Technology Trellis Bioscience, Inc. is discovers and develops novel human antibody therapeutics. It provides the discovery and development of therapeutic antibodies from human B cells. The firm develops the CellSpot antibody discovery platform, which enables the identification of antibodies directly from human blood. The company was founded by Lawrence Kauvar and Stote Ellsworth in 1998 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - |
University of Vermont | Corporate Officer/Principal | - |
Protein Design Labs, Inc.
Protein Design Labs, Inc. Pharmaceuticals: MajorHealth Technology Protein Design Labs, Inc. is a biopharmaceutical company focused on the research, development and commercialization of novel therapies for inflammation and autoimmune diseases, acute cardiac conditions and cancer. PDL markets several biopharmaceutical products in the United States through its hospital sales force and wholly-owned subsidiary, ESP Pharma, Inc. As a company of development of humanized antibodies, It has licensed its patents to numerous pharmaceutical and biotechnology companies, some of which are now paying royalties on net sales of licensed products. | Corporate Officer/Principal | - |
Ausbildung von James Posada
University of Vermont | Doctorate Degree |
Eastern Connecticut State University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
MERCK & CO., INC. | Health Technology |
ELI LILLY AND COMPANY | Health Technology |
Private Unternehmen | 4 |
---|---|
GlycoFi, Inc.
GlycoFi, Inc. BiotechnologyHealth Technology GlycoFi, Inc. develops biopharmaceutical products. It provides protein production technology to develop, produce and commercialize biotherapeutics products. The company was founded by Tillman Gerngross in 2000 and is headquartered in Lebanon, NH. | Health Technology |
Protein Design Labs, Inc.
Protein Design Labs, Inc. Pharmaceuticals: MajorHealth Technology Protein Design Labs, Inc. is a biopharmaceutical company focused on the research, development and commercialization of novel therapies for inflammation and autoimmune diseases, acute cardiac conditions and cancer. PDL markets several biopharmaceutical products in the United States through its hospital sales force and wholly-owned subsidiary, ESP Pharma, Inc. As a company of development of humanized antibodies, It has licensed its patents to numerous pharmaceutical and biotechnology companies, some of which are now paying royalties on net sales of licensed products. | Health Technology |
Trellis Bioscience, Inc.
Trellis Bioscience, Inc. BiotechnologyHealth Technology Trellis Bioscience, Inc. is discovers and develops novel human antibody therapeutics. It provides the discovery and development of therapeutic antibodies from human B cells. The firm develops the CellSpot antibody discovery platform, which enables the identification of antibodies directly from human blood. The company was founded by Lawrence Kauvar and Stote Ellsworth in 1998 and is headquartered in South San Francisco, CA. | Health Technology |
Resolve Therapeutics LLC
Resolve Therapeutics LLC BiotechnologyHealth Technology Resolve Therapeutics LLC operates as a biotechnology company. It engages in the development of biotechnology drugs. The firm specializes in treatment of debilitating autoimmune diseases such as Systemic Lupus Erythematous and Sjogren’s syndrome. The company was founded by James Posada in 2010 and is headquartered in Seattle, WA. | Health Technology |